The estimated Net Worth of Capital Partners Ii Gp, Llc... is at least $72.4 Millón dollars as of 25 November 2019. Capital Llc owns over 1,250,000 units of OptiNose Inc stock worth over $743,355 and over the last 7 years Capital sold OPTN stock worth over $71,607,500.
Capital has made over 2 trades of the OptiNose Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Capital sold 1,250,000 units of OPTN stock worth $11,462,500 on 25 November 2019.
The largest trade Capital's ever made was selling 2,875,000 units of OptiNose Inc stock on 11 June 2018 worth over $60,145,000. On average, Capital trades about 1,031,250 units every 133 days since 2017. As of 25 November 2019 Capital still owns at least 807,995 units of OptiNose Inc stock.
You can see the complete history of Capital Llc stock trades at the bottom of the page.
Capital's mailing address filed with the SEC is 65 E 55th St #18, New York, NY 10022, USA.
Over the last 19 years, insiders at OptiNose Inc have traded over $144,654,703 worth of OptiNose Inc stock and bought 116,688 units worth $814,936 . The most active insiders traders include Sriram Venkataraman, Capital Partners Ii Gp, Llc... y Rajat Rai. On average, OptiNose Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,645. The most recent stock trade was executed by Anthony J Krick on 17 July 2024, trading 6,845 units of OPTN stock currently worth $7,803.
optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo
OptiNose Inc executives and other stock owners filed with the SEC include: